COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,088 Articles (22,658 medRxiv, 8,430 bioRxiv)

Most recent first Previous |  Page 2264: Articles 22631-22640  | Next

Notable sequence homology of the ORF10 protein introspects the architecture of SARS-COV-2
Hassan, S. S., Attrish, D., Ghosh, S., Pal Choudhury, P., Uversky, V. N., Uhal, B., Lundstrom, K., Rezaei, N., Aljabali, A. A. A., Seyran, M., Pizzol, D., Adadi, P., Abd El-Aziz, T. M., Soares, A., Kandimalla, R., Tambuwala, M., Lal, A., Azad, G. K., P. Sherchan, S., Baetas-da-Cruz, W., Palu, G., Brufsky, A.
10.1101/2020.09.06.284976 — Posted: 2020-09-06
Long-term survival of salmon-attached SARS-CoV-2 at 4 degree as a potential source of transmission in seafood markets
Dai, M., Li, H., Yan, N., Huang, J., Zhao, L., Xu, S., Jiang, S., Pan, C., Liao, M.
10.1101/2020.09.06.284695 — Posted: 2020-09-06
Computationally validated SARS-CoV-2 CTL and HTL Multi-Patch Vaccines designed by reverse epitomics approach, shows potential to cover large ethnically distributed human population worldwide
Srivastava, S., Verma, S., Kamthania, M., Agarwal, D., Saxena, A. K., Kolbe, M., Singh, S., Kotnis, A., Rathi, B., Nayar, S. A., Shin, H.-J., Vashisht, K., Pandey, K. C.
10.1101/2020.09.06.284992 — Posted: 2020-09-06
New insights into nCOVID-19 binding domain and its cellular receptors
Garg, A., Kumar, G., Sinha, S.
10.1101/2020.09.06.285023 — Posted: 2020-09-06
Pre-clinical studies of a recombinant adenoviral mucosal vaccine to prevent SARS-CoV-2 infection
Moore, A. C., Dora, E. G., Peinovich, N., Tucker, K. P., Lin, K., Cortese, M., Tucker, S.
10.1101/2020.09.04.283853 — Posted: 2020-09-06 Discussion: Onsite
Genomic analysis reveals local transmission of SARS-CoV-2 in early pandemic phase in Peru
Padilla Rojas, C., Vega Chozo, K., Galarza Perez, M., Bailon Calderon, H., Lope Pari, P., Balbuena Torres, J., Garcia Neyra, D., Huaringa Nunez, M., Rojas Serrano, N., Caceres Rey, O.
10.1101/2020.09.05.284604 — Posted: 2020-09-06
Vapur: A Search Engine to Find Related Protein - Compound Pairs in COVID-19 Literature
Koksal, A., Donmez, H., Ozcelik, R., Ozkirimli, E., Ozgur, A.
10.1101/2020.09.05.284224 — Posted: 2020-09-05
Immunological characteristics govern the changing severity of COVID-19 during the transition to endemicity
Lavine, J. S., Bjornstad, O. N., Antia, R.
10.1101/2020.09.03.20187856 — Posted: 2020-09-05
Swab pooling for large-scale RT-qPCR screening of SARS-CoV-2
Christoff, A. P., Cruz, G. N. F., Sereia, A. F. R., Boberg, D. R., de Bastiani, D. C., Yamanaka, L. E., Fongaro, G., Stoco, P. H., Bazzo, M. L., Grisard, E. C., Hernandes, C., de Oliveira, L. F. V.
10.1101/2020.09.03.20187732 — Posted: 2020-09-05 Discussion: Onsite
Viable virus aerosol propagation by PAP circuit leak and mitigation with a ventilated patient hood: a model for improving health care worker safety in the COVID-19 pandemic
Landry, S. A., Barr, J., MacDonald, M., Subedi, D., Mansfield, D., Hamilton, G., Edwards, B., Joosten, S.
10.1101/2020.09.04.20187922 — Posted: 2020-09-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).